Depression and Anxiety Trial, Recruiting NCT07618676 Sponsor: Institute for Oncology and Radiology of Serbia Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT07618676
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have never previously received Nitrous Oxide (also known as laughing gas)
  • People of any gender aged between 18 and 65 years old (inclusive)
  • People who have read and signed a consent form agreeing to take part, which must be completed before any part of the study begins

Who may not be able to join:

  • People who have an infection at the site on the body where a needle would be inserted
  • People who are pregnant
  • People who have raised pressure inside the skull (confirm with trial site)
  • People who have a Vitamin B12 deficiency
  • People whose blood circulation is unstable (confirm with trial site)
  • People with a BMI (body mass index) over 35
  • People who are not fully alert and responsive, as measured by a standard medical awareness scale called the Glasgow Coma Scale (confirm with trial site)
  • People who experience ongoing long-term pain
  • People who have a neurological condition affecting the brain or nervous system
  • People who have a condition affecting the blood or blood cells
  • Participants may be withdrawn from the trial if more than two attempts are needed to insert a needle into a vein
  • Participants may be withdrawn if they experience a side effect or medical reaction that requires them to stop early
  • Participants may be withdrawn if they choose to withdraw their consent at any point

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ana Cvetković, MD, PhD, Institute for Oncology and Radiology of Serbia

Phone: +381 11 2067 100

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Institute for Oncology and Radiology of Serbia
Registry
ClinicalTrials.gov
Start date
6 June 2025
Est. completion
6 June 2026

Where this trial is recruiting

🇷🇸 Serbia

Primary endpoints

Pain Intensity During Needle Insertion; Pain Intensity During Catheter Placement; Pain Intensity Post-Intervention

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov